Helen M. Thackray
2016 - GlycoMimetics
In 2016, Helen M. Thackray earned a total compensation of $809.4K as Chief Medical Officer at GlycoMimetics, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,642 |
|---|---|
| Option Awards | $232,170 |
| Salary | $392,700 |
| Other | $3,927 |
| Total | $809,439 |
Thackray received $392.7K in salary, accounting for 49% of the total pay in 2016.
Thackray also received $180.6K in non-equity incentive plan, $232.2K in option awards and $3.9K in other compensation.
Rankings
In 2016, Helen M. Thackray's compensation ranked 9,240th out of 14,075 executives tracked by ExecPay. In other words, Thackray earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,240 out of 14,075 | 34th |
Division Manufacturing | 3,569 out of 5,489 | 35th |
Major group Chemicals And Allied Products | 1,235 out of 1,895 | 35th |
Industry group Drugs | 980 out of 1,538 | 36th |
Industry Pharmaceutical Preparations | 776 out of 1,176 | 34th |
Source: SEC filing on April 20, 2017.
Thackray's colleagues
We found three more compensation records of executives who worked with Helen M. Thackray at GlycoMimetics in 2016.